Variant report

Variant	nsv960426
Chromosome Location	chr17:17285422-17287949
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:74)
CpG islands
(count:306)
Chromatin interactive
region (count:5)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:74 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CTCF	chr17:17286772-17286967	T-47D	breast:	n/a	n/a
2	CTCF	chr17:17287050-17287384	T-47D	breast:	n/a	n/a
3	EP300	chr17:17287049-17287407	T-47D	breast:	n/a	n/a
4	GATA2	chr17:17286625-17286873	K562	blood:	n/a	n/a
5	GATA3	chr17:17287210-17287433	T-47D	breast:	n/a	n/a
6	HEY1	chr17:17286833-17287357	K562	blood:	n/a	n/a
7	HEY1	chr17:17286675-17287469	K562	blood:	n/a	n/a
8	MYC	chr17:17287245-17287306	HUVEC	blood vessel:	n/a	n/a
9	MYC	chr17:17286997-17287056	MCF-7	breast:	n/a	n/a
10	MYC	chr17:17287087-17287303	MCF-7	breast:	n/a	n/a
11	MYC	chr17:17287188-17287319	K562	blood:	n/a	n/a
12	MYC	chr17:17287048-17287068	MCF-7	breast:	n/a	n/a
13	MYC	chr17:17287262-17287309	HepG2	liver:	n/a	n/a
14	MYC	chr17:17287100-17287308	MCF-7	breast:	n/a	n/a
15	MYC	chr17:17286843-17286988	MCF-7	breast:	n/a	n/a
16	MYC	chr17:17286855-17287380	MCF-7	breast:	n/a	n/a
17	MYC	chr17:17287171-17287301	MCF-7	breast:	n/a	n/a
18	POLR2A	chr17:17286584-17287391	GM12878	blood:	n/a	n/a
19	POLR2A	chr17:17286712-17286714	MCF-7	breast:	n/a	n/a
20	POLR2A	chr17:17287098-17287363	H1-hESC	embryonic stem cell:	n/a	n/a
21	POLR2A	chr17:17286757-17286781	Hela-S3	cervix:	n/a	n/a
22	POLR2A	chr17:17286498-17287460	HepG2	liver:	n/a	n/a
23	POLR2A	chr17:17286807-17286980	GM12878	blood:	n/a	n/a
24	POLR2A	chr17:17286745-17287323	MCF-7	breast:	n/a	n/a
25	POLR2A	chr17:17287276-17287323	H1-hESC	embryonic stem cell:	n/a	n/a
26	POLR2A	chr17:17286819-17287386	GM12878	blood:	n/a	n/a
27	POLR2A	chr17:17286567-17287262	GM12892	blood:	n/a	n/a
28	POLR2A	chr17:17287106-17287213	H1-hESC	embryonic stem cell:	n/a	n/a
29	POLR2A	chr17:17287212-17287310	A549	lung:	n/a	n/a
30	POLR2A	chr17:17286794-17287298	Hela-S3	cervix:	n/a	n/a
31	POLR2A	chr17:17286565-17287431	H1-hESC	embryonic stem cell:	n/a	n/a
32	POLR2A	chr17:17286646-17286707	Hela-S3	cervix:	n/a	n/a
33	POLR2A	chr17:17286757-17287375	GM12891	blood:	n/a	n/a
34	POLR2A	chr17:17286830-17287319	A549	lung:	n/a	n/a
35	POLR2A	chr17:17286587-17287311	K562	blood:	n/a	n/a
36	POLR2A	chr17:17287111-17287355	GM12891	blood:	n/a	n/a
37	POLR2A	chr17:17286855-17287070	Hela-S3	cervix:	n/a	n/a
38	POLR2A	chr17:17286801-17287348	A549	lung:	n/a	n/a
39	POLR2A	chr17:17286850-17287343	H1-hESC	embryonic stem cell:	n/a	n/a
40	POLR2A	chr17:17287169-17287321	HepG2	liver:	n/a	n/a
41	POLR2A	chr17:17286721-17287292	MCF-7	breast:	n/a	n/a
42	POLR2A	chr17:17286730-17287109	Hela-S3	cervix:	n/a	n/a
43	POLR2A	chr17:17286817-17287343	H1-hESC	embryonic stem cell:	n/a	n/a
44	POLR2A	chr17:17287117-17287309	HUVEC	blood vessel:	n/a	n/a
45	POLR2A	chr17:17286685-17287416	GM12892	blood:	n/a	n/a
46	POLR2A	chr17:17287166-17287288	ProgFib	skin:	n/a	n/a
47	POLR2A	chr17:17287234-17287272	H1-hESC	embryonic stem cell:	n/a	n/a
48	POLR2A	chr17:17286604-17287388	GM12878	blood:	n/a	n/a
49	POLR2A	chr17:17287235-17287259	Gliobla	brain:	n/a	n/a
50	POLR2A	chr17:17286667-17287347	GM12892	blood:	n/a	n/a

(count:306 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr17:17287344-17287394	AG10803	skin:	n/a
2	chr17:17287344-17287394	AG10803	skin:	n/a
3	chr17:17287344-17287394	MCF10A-Er-Src	breast:	n/a
4	chr17:17287104-17287154	AG09309	skin:	n/a
5	chr17:17286854-17286904	PANC-1	pancreas:	n/a
6	chr17:17287690-17287740	GM12892	blood:	n/a
7	chr17:17287690-17287740	ProgFib	skin:	n/a
8	chr17:17287690-17287740	Hela-S3	cervix:	n/a
9	chr17:17287690-17287740	U87	brain:	n/a
10	chr17:17287344-17287394	IMR90	lung:	fetal
11	chr17:17287690-17287740	HEK293	kidney:	embryo
12	chr17:17287690-17287740	IMR90	lung:	fetal
13	chr17:17287104-17287154	NH-A	brain:	n/a
14	chr17:17286991-17287041	AG10803	skin:	n/a
15	chr17:17287344-17287394	SAEC	small airway:	n/a
16	chr17:17287104-17287154	HRPEpiC	eye:	n/a
17	chr17:17287344-17287394	U87	brain:	n/a
18	chr17:17287104-17287154	HEK293	kidney:	embryo
19	chr17:17287344-17287394	CMK	blood:	n/a
20	chr17:17287104-17287154	HRE	kidney:	n/a
21	chr17:17287690-17287740	MCF10A-Er-Src	breast:	n/a
22	chr17:17286854-17286904	HMEC	breast:	n/a
23	chr17:17286854-17286904	BJ	skin:	n/a
24	chr17:17286991-17287041	MCF10A-Er-Src	breast:	n/a
25	chr17:17286991-17287041	HRE	kidney:	n/a
26	chr17:17287690-17287740	NH-A	brain:	n/a
27	chr17:17286991-17287041	H1-hESC	embryonic stem cell:	embryo
28	chr17:17287104-17287154	HCPEpiC	choroid plexus:	n/a
29	chr17:17287104-17287154	A549	lung:	n/a
30	chr17:17286854-17286904	LNCaP	prostate:	n/a
31	chr17:17286854-17286904	AoSMC	blood vessel:	n/a
32	chr17:17287690-17287740	SK-N-MC	brain:	n/a
33	chr17:17286854-17286904	SK-N-MC	brain:	n/a
34	chr17:17287104-17287154	K562	blood:	n/a
35	chr17:17287104-17287154	AG04449	skin:	fetal
36	chr17:17286991-17287041	HNPCEpiC	eye:	n/a
37	chr17:17287690-17287740	HUVEC	blood vessel:	n/a
38	chr17:17286854-17286904	HIPEpiC	eye:	n/a
39	chr17:17286854-17286904	HEEpiC	esophagus:	n/a
40	chr17:17287104-17287154	ovcar-3	ovarian:	n/a
41	chr17:17286854-17286904	SAEC	small airway:	n/a
42	chr17:17287690-17287740	HRPEpiC	eye:	n/a
43	chr17:17287104-17287154	Hela-S3	cervix:	n/a
44	chr17:17286991-17287041	SK-N-SH	brain:	n/a
45	chr17:17286991-17287041	HEEpiC	esophagus:	n/a
46	chr17:17287104-17287154	HCT-116	colon:	n/a
47	chr17:17286991-17287041	HepG2	liver:	n/a
48	chr17:17286854-17286904	AG04449	skin:	fetal
49	chr17:17287104-17287154	GM12891	blood:	n/a
50	chr17:17287690-17287740	HIPEpiC	eye:	n/a

(count:5 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr16:89626961..89627762-chr17:17286752..17287733,3	Hela-S3	cervix:
2	chr16:89626780..89628627-chr17:17287230..17288747,2	MCF-7	breast:
3	chr16:89626908..89627427-chr17:17287227..17287745,2	MCF-7	breast:
4	chr17:17283894..17285610-chr17:17289110..17290845,2	K562	blood:
5	chr16:89629617..89632249-chr17:17285725..17287253,2	MCF-7	breast:

No data

Variant related genes	Relation type
RPL13P12	TF binding region
RPL13P12	CpG island
ENSG00000167526	chromatin interactions
ENSG00000200084	chromatin interactions

Extended variants
information (count: 117 )
Associated
traits (count: 159 )

Variant overlapped rSNPs/rCNVs (count:117 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs76896613	chr17:17285440-17285441	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs562087372	chr17:17285454-17285455	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs530778122	chr17:17285485-17285486	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs146839780	chr17:17285496-17285497	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs78995576	chr17:17285513-17285514	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs190631928	chr17:17285527-17285528	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs546782361	chr17:17285585-17285586	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs566685344	chr17:17285604-17285605	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs535764779	chr17:17285621-17285622	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs555604617	chr17:17285643-17285644	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs150473262	chr17:17285651-17285652	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs181698513	chr17:17285697-17285698	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs73981919	chr17:17285704-17285705	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs550830662	chr17:17285739-17285740	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs540290732	chr17:17285740-17285741	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs6502588	chr17:17285746-17285747	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs549643498	chr17:17285789-17285790	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs35047948	chr17:17285808-17285809	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs6502589	chr17:17285817-17285818	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs138333858	chr17:17285820-17285821	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs562625952	chr17:17285892-17285893	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs146242747	chr17:17285894-17285895	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs530964185	chr17:17285899-17285900	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs544279356	chr17:17285974-17285975	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs149550985	chr17:17285979-17285980	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs11393535	chr17:17286003-17286004	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs11384716	chr17:17286010-17286011	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs555056985	chr17:17286014-17286015	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs373844383	chr17:17286015-17286016	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs397971296	chr17:17286016-17286017	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs186306028	chr17:17286115-17286116	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs546645604	chr17:17286126-17286127	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs146357326	chr17:17286155-17286156	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs538909208	chr17:17286189-17286190	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs191290566	chr17:17286240-17286241	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs372968164	chr17:17286279-17286280	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs565761724	chr17:17286299-17286300	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs139083374	chr17:17286345-17286346	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs537886695	chr17:17286346-17286347	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs557478365	chr17:17286380-17286381	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs143095995	chr17:17286407-17286408	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs574999553	chr17:17286429-17286430	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs533897302	chr17:17286436-17286437	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs183095977	chr17:17286454-17286455	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs147491391	chr17:17286466-17286467	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs542823033	chr17:17286478-17286479	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs556470334	chr17:17286481-17286482	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs576250486	chr17:17286556-17286557	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs545250403	chr17:17286620-17286621	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs62064865	chr17:17286634-17286635	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:159)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Burkitt''s lymphoma	19759907	CNVD
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Chordoma	21602918	CNVD
Miller-Dieker syndrome	22283845	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Cancer	22429812	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Ewing''s sarcoma	21437220	CNVD
Follicular lymphoma	19010834	CNVD
Colorectal cancer	20709793	CNVD
Acute myeloid leukemia	16864856	CNVD
Endometrial cancer	22040021	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Breast cancer	22028636	CNVD
Breast cancer	20837533	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
colon cancer	17210682	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Chronic lymphocytic leukemia	17971485	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16461572	CNVD
Colorectal cancer	16272173	CNVD
Follicular lymphoma	17170743	CNVD
Human rectal carcinomas	16397240	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20724749	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Acute myeloid leukemia	17237825	CNVD
Colorectal cancer	21645411	CNVD
HIV/AIDS	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
HIV/AIDS	17953491	CNVD
HIV/AIDS	20877625	CNVD
Immune disease	21076436	CNVD
Rheumatoid arthritis	17953491	CNVD
Type 1 diabetes	17953491	CNVD
HIV/AIDS	15637236	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Neurofibromatosis	18196300	CNVD
Adenoid cystic carcinoma	18332873	CNVD
Colorectal cancer	16774939	CNVD
Breast cancer	17001317	CNVD
Rhabdomyosarcoma	16790082	CNVD
Charcot-marie-tooth disease	16463004	CNVD
Osteosarcoma	22292074	CNVD
Breast cancer	17603634	CNVD
Charcot	16760730	CNVD
Mental retardation	17901693	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
ovarian endometriomas	16273235	CNVD
Ovarian cancer	21720365	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Gastric cancer	18160780	CNVD
Smith-Magenis syndrome	18923513	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Austim spectrum disorder	21302340	CNVD
Autism	22492990	CNVD
Congenital abnormalities	21549014	CNVD
Developmental delay	18414209	CNVD
Developmental delay	21549014	CNVD
Epilepsy	20970697	CNVD
Mental retardation	18414209	CNVD
Mental retardation	21549014	CNVD
Smith-Magenis syndrome	21981782	CNVD
Smith-Magenis syndrome	20188345	CNVD
Smith-Magenis syndrome	16775514	CNVD
Smith-Magenis syndrome	22585170	CNVD
Smith-Magenis syndrome	22241247	CNVD
Autism	20970697	CNVD
Mental retardation	19951919	CNVD
Potocki-Lupski syndrome	21271655	CNVD
Potocki-lupski syndrome	17357070	CNVD
Potocki-lupski syndrome	20110824	CNVD
Potocki-lupski syndrome	18923514	CNVD
Potocki-lupski syndrome	22241247	CNVD
Potocki-lupski syndrome	20188345	CNVD
Schizophrenia	21399695	CNVD
Mental retardation	16773131	CNVD
Adenocarcinoma	19607727	CNVD
Squamous cell cancer	19607727	CNVD
Non-small cell lung cancer	21829676	CNVD
Glioblastoma multiforme	17002787	CNVD
Charcot-marie-tooth disease	22470819	CNVD
Neurofibromatosis	22470819	CNVD
Neuropathy	22470819	CNVD
Smith-Magenis syndrome	18301319	CNVD
Smith-Magenis syndrome	17357070	CNVD
Smith-Magenis syndrome	18469339	CNVD
Smith-Magenis syndrome	22241097	CNVD
Smith-Magenis syndrome	22470819	CNVD
Tourette syndrome	18923514	CNVD
Type 1 diabetes	22470819	CNVD
Potocki-lupski syndrome	18469339	CNVD
Follicular lymphoma	20505157	CNVD
T-cell lymphomas	19863542	CNVD
Neuropathy	17597781	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	17015230	CNVD
Smith-Magenis syndrome	17597781	CNVD
Potocki-lupski syndrome	18059269	CNVD
Potocki-lupski syndrome	17597781	CNVD
Mental retardation	17847001	CNVD
Multiple myeloma	16616336	CNVD
Breast cancer	20409316	CNVD
Breast cancer	21509527	CNVD
Ductal carcinoma	22052326	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Multiple myeloma	17550852	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Autism	22543975	CNVD

Chromatin state (count:55 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:17281000-17288600	Weak transcription	Fetal Lung	lung
2	chr17:17281200-17287400	Weak transcription	Fetal Brain Female	brain
3	chr17:17281600-17290600	Weak transcription	Esophagus	oesophagus
4	chr17:17282200-17285800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
5	chr17:17282200-17285800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
6	chr17:17282200-17285800	Enhancers	Brain Anterior Caudate	brain
7	chr17:17282200-17285800	Enhancers	Brain Inferior Temporal Lobe	brain
8	chr17:17282200-17285800	Enhancers	Brain Substantia Nigra	brain
9	chr17:17282200-17286200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
10	chr17:17282400-17286000	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
11	chr17:17282800-17285600	Enhancers	Brain Germinal Matrix	brain
12	chr17:17282800-17285800	Enhancers	Fetal Thymus	thymus
13	chr17:17284000-17285800	Enhancers	Fetal Muscle Leg	muscle
14	chr17:17284000-17287200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
15	chr17:17284200-17290000	Weak transcription	Pancreas	Pancrea
16	chr17:17284400-17285800	Enhancers	Fetal Brain Male	brain
17	chr17:17284400-17287400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
18	chr17:17284800-17286600	Enhancers	Cortex derived primary cultured neurospheres	brain
19	chr17:17285000-17285800	Enhancers	Hela-S3	cervix
20	chr17:17285200-17287200	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
21	chr17:17285400-17285600	Enhancers	Brain Hippocampus Middle	brain
22	chr17:17285400-17285800	Bivalent Enhancer	HUVEC	blood vessel
23	chr17:17285400-17286000	Bivalent Enhancer	HepG2	liver
24	chr17:17285400-17286800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
25	chr17:17285400-17288400	Weak transcription	Brain Cingulate Gyrus	brain
26	chr17:17285400-17288800	Weak transcription	Brain Angular Gyrus	brain
27	chr17:17285600-17287800	Weak transcription	Brain Germinal Matrix	brain
28	chr17:17285600-17288400	Weak transcription	Brain Hippocampus Middle	brain
29	chr17:17285800-17286400	Weak transcription	Fetal Brain Male	brain
30	chr17:17285800-17287400	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
31	chr17:17285800-17287600	Weak transcription	Fetal Muscle Leg	muscle
32	chr17:17285800-17288200	Weak transcription	Brain Substantia Nigra	brain
33	chr17:17285800-17288400	Weak transcription	Brain Inferior Temporal Lobe	brain
34	chr17:17285800-17288800	Weak transcription	Brain Anterior Caudate	brain
35	chr17:17285800-17290800	Weak transcription	Hela-S3	cervix
36	chr17:17286000-17286200	Enhancers	Fetal Muscle Trunk	muscle
37	chr17:17286000-17288400	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
38	chr17:17286000-17289000	Weak transcription	Fetal Intestine Small	intestine
39	chr17:17286200-17286600	Bivalent Enhancer	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
40	chr17:17286200-17287600	Weak transcription	Fetal Muscle Trunk	muscle
41	chr17:17286400-17287600	Enhancers	Fetal Brain Male	brain
42	chr17:17286800-17287200	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
43	chr17:17287200-17287800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
44	chr17:17287200-17289800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
45	chr17:17287200-17289800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
46	chr17:17287400-17287600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
47	chr17:17287400-17288400	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
48	chr17:17287400-17288600	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
49	chr17:17287400-17289000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
50	chr17:17287400-17289600	Enhancers	Fetal Brain Female	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links